Zeon Lifesciences appoints GK Sharma as Group Technical Director
Sharma brings a wealth of expertise in optimizing manufacturing processes for fermentation-based APIs and sterile injectables
Sharma brings a wealth of expertise in optimizing manufacturing processes for fermentation-based APIs and sterile injectables
The freshly infused capital will primarily be deployed towards expansion and research & development
Previously, Sujatha has held leadership positions at prominent organizations, including Publicis Sapient, Infinite Computer Solutions, and Capgemini
The new lenders – JP Morgan, HSBC, and Barclays provided fresh funding
Our Q3 FY25 revenue was at Rs. 1,384.1 crore with an EBITDA of Rs. 360 crore resulting in a 26% EBITDA margin
The 33% year-over-year revenue growth and a remarkable 45% surge in gross profit reflect our strong market presence and efficient execution across therapeutic segments
PAT after MI is Rs. 41 crore which is 162% increase
Subscribe To Our Newsletter & Stay Updated